FTC Report Shows that Oil Sector and Pharmaceutical Sector Mergers Are Under the Antitrust Spotlight

January 22, 2013

The U.S. Federal Trade Commission (“FTC”) issued a data report on January 4 regarding its horizontal merger investigation and enforcement action record over the past fifteen years. The report shows, sector-by-sector, the level of market concentration triggering FTC action, as well as the impact of other antitrust enforcement variables including the presence of hot documents, the presence of strong customer complaints, the number of significant competitors, and entry conditions.

Read “FTC Report Shows that Oil Sector and Pharmaceutical Sector Mergers Are Under the Antitrust Spotlight.”